Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1365023 | 0.94 | DGKA (0.67) | DGKAALDH1A1NAAAFAAHDNM1 | |
| SCHEMBL19032628 | 0.94 | DGKA (0.67) | DGKANAAAFAAHDNM1HTR2C | |
| SCHEMBL1366455 | 0.92 | DGKA (0.70) | DGKAALDH1A1NAAAFAAHDNM1 | |
| SCHEMBL6120282 | 0.92 | DGKA (0.70) | DGKAALDH1A1NAAAFAAHDNM1 | |
| SCHEMBL1364973 | 0.92 | DGKA (0.70) | DGKAALDH1A1NAAAFAAHDNM1 | |
| SCHEMBL25343011 | 0.92 | DGKA (0.70) | DGKAALDH1A1NAAAFAAHDNM1 | |
| SCHEMBL22092052 | 0.92 | DGKA (0.70) | DGKAALDH1A1NAAAFAAHDNM1 | |
| SCHEMBL1366913 | 0.92 | DGKA (0.70) | DGKAALDH1A1NAAAFAAHDNM1 | |
| SCHEMBL11639639 | 0.92 | DGKA (0.70) | DGKAALDH1A1NAAAFAAHDNM1 | |
| SCHEMBL21811479 | 0.92 | DGKA (0.70) | DGKAALDH1A1NAAAFAAHDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113980117-B | Fenpyroximate antigen and preparation method and application thereof | 西南大学 | 2024-07-12 | — | — | CN | claimed |
| CN-117820460-A | Methoxypiperidine ethyl antigen and preparation method and application thereof | 西南大学 | 2024-04-05 | — | — | CN | claimed |
| CN-114560834-B | Spirodiclofen hapten, antigen and antibody as well as preparation methods and applications thereof | 西南大学 | 2024-02-09 | — | — | CN | claimed |
| CN-114560834-A | Spirodiclofen hapten, antigen and antibody as well as preparation method and application thereof | 西南大学 | 2022-05-31 | — | — | CN | claimed |
| CN-113980117-A | Fenpyroximate antigen and preparation method and application thereof | 西南大学 | 2022-01-28 | — | — | CN | claimed |
| WO-2025126793-A1 | METHOD FOR PRODUCING POLYCARBOXYLIC ACID ESTER COMPOUND | 本州化学工業株式会社 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025126794-A1 | METHOD FOR PRODUCING POLYCARBOXYLIC ACID ESTER COMPOUND | 本州化学工業株式会社 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025106386-A1 | A CYCLIC PEPTIDE FOR TRAPPING INTERLEUKIN-1 BETA | MERCK SHARP & DOHME LLC (US) | 2025-05-22 | — | — | WO | disclosed |
| CN-113980117-B | Fenpyroximate antigen and preparation method and application thereof | 西南大学 | 2024-07-12 | — | — | CN | disclosed |
| US-12030834-B2 | Methods of synthesizing 4-valyloxybutyric acid | XWPharma Ltd. (KY) | 2024-07-09 | — | — | US | disclosed |
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-117820460-A | Methoxypiperidine ethyl antigen and preparation method and application thereof | 西南大学 | 2024-04-05 | — | — | CN | disclosed |
| WO-2005121904-A1 | CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005121204-A2 | POLYHYDROXYALKANOIC ACID HAVING VINYL, ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| EP-0777656-B1 | NOVEL DNA-TARGETED ALKYLATING AGENTS | AUCKLAND DIVISION CANCER SOC O (NZ) | 2004-04-14 | — | — | EP | disclosed |
| US-5968933-A | ANTITUMOR AGENTS AND BINDING DNA FOR MUTAGENESIS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) | 1999-10-19 | — | — | US | disclosed |
| EP-0777656-A4 | NOVEL DNA-TARGETED ALKYLATING AGENTS | CANCER SOC AUCKLAND DIV NZ INC (NZ) | 1998-04-15 | — | — | EP | disclosed |
| EP-0777656-A1 | NOVEL DNA-TARGETED ALKYLATING AGENTS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND (INCORPORATED) (NZ) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996006831-A1 | NOVEL DNA-TARGETED ALKYLATING AGENTS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) | 1996-03-07 | — | — | WO | disclosed |
| EP-0137426-A2 | 2-Mercaptothiazole derivatives, process for their preparation and utilization of 2-mercaptothiazole derivatives in pharmaceutical compounds | BAYER AG (DE) | 1985-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030834-B2 | Methods of synthesizing 4-valyloxybutyric acid | GABBR1, GABBR2, GABRB3 | DGKA 979/4885ALDH1A1 2199/4885NAAA 326/4885 |
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | F12, F10, PCNA | DGKA 2032/4885ALDH1A1 838/4885NAAA 1666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.